🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Progress in exercise interventions for autism spectrum disorder: exploring underlying mechanisms.

PMID: 41551188 · DOI: 10.3389/fpsyt.2025.1649005 · Frontiers in psychiatry, 2025 · Chaofan Wang, Yuanxiang Zhang, Jimiao Zhu, Zhiyi Lin
📄 Abstract

ASD is a neurodevelopmental disorder with specific core symptoms. Physical activity has been demonstrated to positively influence the pathological mechanisms underlying autism and to alleviate associated symptoms. A comprehensive synthesis was conducted by reviewing and integrating relevant literature. Literature review revealed that the mechanism of physical activity intervention in autism primarily involves modulation through neuronal factors, glial cells, and gut microbiota. Neuronal factors include brain-derived neurotrophic factor, axonal protein families, and neurotransmitters. Additionally, physical activity helps alleviate stereotypical behaviors and internal anxiety in individuals with ASD, reduce obesity and cardiovascular diseases in some patients, and enhance social communication skills.

Confidence: 0.07 · 3 полей извлечено
Идентификация (6 полей)
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
0.00
In vivo
Physical activity intervention in autism involves modulation through neuronal factors, glial cells, and gut microbiota; includes brain-derived neurotrophic factor, axonal protein families, and neurotransmitters; alleviates stereotypical behaviors, internal anxiety, reduces obesity and cardiovascular diseases, enhances social communication skills.
0.90
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
Valproic acid-induced autism model in rats; perinatal hyperandrogenization and immune activation in rodents model subtypes of autism.
0.90
Diet/model
Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid.
0.90
Клиника (11 полей)
Drug
0.00
Indication
0.00
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00